logo
Centre's Tele-MANAS logs over 24 lakh calls since 2022 launch, becomes mental health lifeline

Centre's Tele-MANAS logs over 24 lakh calls since 2022 launch, becomes mental health lifeline

The Hindu8 hours ago
Tele-MANAS helpline, the flagship initiative of Ministry of Health and Family Welfare, has emerged as a critical lifeline for mental health support across India as, since its launch in 2022, it had received over 24 lakh calls -- an average of over 2500 calls a day, according to an RTI reply.
Operated under the aegis of the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, the helpline was launched on October 10, 2022.
Between December 1, 2022 and July 24, 2025, the helpline has attended to an astounding 24,25,885 calls from 37 states and union territories, the RTI reply said.
This translates to an average of 2,511 calls per day, underscoring the growing urgency of mental health concerns in the country. The Right to Information (RTI) was filed by a Kota-based activist and advocate Sujeet Swami in June 2024 and the response was provided on July 31.
The helpline, designed to provide 24x7 free tele-mental health services, especially to remote and underserved areas, has become a beacon of hope for millions. The data highlights a diverse range of callers, with the 31-60 age group leading with 2,86,286 calls (approximately 296 calls per day), followed by the 19-30 age group with 1,98,409 calls (205 calls per day). Meanwhile, the 60 years and above age group contributed 37,745 calls (39 calls per day).
This distribution reflects the pervasive nature of mental health challenges across all age demographics. The helpline received the most number of calls from Uttar Pradesh at 4,39,164 calls (455 calls per day), indicating a significant mental health burden in the state.
In contrast, Lakshadweep recorded the lowest 722 calls. Tamil Nadu recorded 3,87,190 calls, Odisha 2,30,117, Maharashtra 1,83,442 calls and Rajasthan also 39,996 calls.
The calls reflected a variety of stressors with 43,346 calls linked to study stress, 22,740 job-related issues, 73,377 financial problems, 17,826 associated with relationship issues, and 18,377 stemming from family conflicts, the RTI data showed.
Sujeet Swami, who spearheaded the RTI effort, emphasized the gravity of the situation and said, "Despite a lack of widespread awareness and promotion, the Tele-MANAS helpline is receiving 2,511 calls daily. This is a clear indicator that mental health is a pressing national issue.'
'The central government and state administrations must now seriously consider developing a uniform National Mental Health Policy to address this growing crisis," he said.
Swami further noted that while awareness about mental health is increasing, many individuals still hesitate to seek help openly. "People often struggle silently or seek solutions from untrained family members, which can exacerbate their problems. There is an urgent need for robust awareness campaigns and accessible mental health infrastructure," he added.
The Tele-MANAS helpline 14416 or 1-800-891-4416, supports multiple languages, ensuring inclusivity across India's diverse population. Swami said in light of the escalating mental health concerns among minors, eight mental health experts, including himself, from Rajasthan, Madhya Pradesh, and Haryana have filed a Public Interest Litigation (PIL) with the Rajasthan High Court Jaipur Bench.
The petition demands the implementation of a uniform mental health curriculum and the mandatory appointment of psychological counsellors in all schools, colleges, and universities across Rajasthan, regardless of their private, government, or deemed status.
The PIL highlights suicide data for individuals up to 25 years of age in Kota, Jhalawar, Baran, Sikar, Jodhpur, and Jaipur from 2020 to 2025, underscoring the urgent need for enhanced mental health support in educational institutions.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cardiologist reveals the simple sleep habit that is his #1 recommendation for controlling blood pressure
Cardiologist reveals the simple sleep habit that is his #1 recommendation for controlling blood pressure

Time of India

timean hour ago

  • Time of India

Cardiologist reveals the simple sleep habit that is his #1 recommendation for controlling blood pressure

Regulate circadian rhythm Lower overnight cortisol levels Improve heart rate variability Support blood pressure regulation The Science Behind Sleep and Hypertension Not Just About More Hours in Bed A Clock-Based Habit With Big Payoffs You Might Also Like: Whole plant-based proteins can slash high blood pressure risk, but new study reveals a crucial catch When it comes to managing blood pressure, most people immediately think of diet, exercise, or medication. But according to US-based cardiologist Dr. Sanjay Bhojraj , one of the most overlooked remedies could be as simple as watching the clock before a recent Instagram post, Dr. Bhojraj shared that sleep consistency plays a critical role in regulating blood pressure. 'Most people think blood pressure control is all about diet and exercise. But here's something I tell every patient: your sleep schedule matters just as much,' he number one recommendation? Go to bed and wake up at the same time every day — even on weekends. While it may sound basic, the cardiologist explained that the payoff can be significant. A stable sleep routine helps:'It's not even necessarily about more sleep; it's about consistent sleep,' Dr. Bhojraj added. 'That consistency tells your body when to rest, when to repair, and when to regulate blood pressure.'Dr. Bhojraj's advice is echoed by guidance from the Mayo Clinic , which warns that chronic sleep deprivation can be a direct contributor to high blood pressure. Adults are advised to aim for seven to nine hours of sleep each night, while those who consistently sleep fewer than six hours may face a greater risk of note that poor sleep disrupts hormone balance, increases stress, and can lead to weight gain and diabetes — all risk factors for heart disease. Conversely, consistent and restorative rest allows the body to regulate stress hormones and metabolism, which supports long-term cardiovascular health Interestingly, Dr. Bhojraj stressed that blood pressure benefits are less about increasing the number of hours slept and more about setting a routine. 'You really don't need to oversleep to compensate,' he noted. Too much sleep, in fact, has its own downsides, such as raising blood sugar levels and promoting weight like obstructive sleep apnea also complicate the picture. The Mayo Clinic cautions that the disorder, which causes interrupted breathing at night, is a hidden but common factor behind both poor sleep and high blood Bhojraj, founder of the wellness program Well12, emphasizes a holistic approach to heart health that goes beyond prescriptions. While nutrition, exercise, and stress management are central pillars, he believes sleep deserves equal advice is refreshingly simple: pay attention to your clock. Whether you're managing hypertension or just trying to lower your long-term risk, going to bed and waking up on schedule may be one of the most effective — and underrated — tools available.

ICAR-KVK Longding introduces milky mushroom cultivation
ICAR-KVK Longding introduces milky mushroom cultivation

Time of India

timean hour ago

  • Time of India

ICAR-KVK Longding introduces milky mushroom cultivation

Itanagar: The Indian Council of Agricultural Research-Krishi Vigyan Kendra (ICAR-KVK) Longding has successfully introduced milky mushroom cultivation for the first time in Longding district. A team of scientists led by ICAR-KVK Longding senior-scientist and head Uttpal Kumar Bhattacharya and plant protection subject matter specialist Deep Narayan Mishra introduced the cultivation of milky mushroom (calocybe indica). The Kanubari-based KVK helped the farmers to adopt new technologies and was guided by Mishra in proper cultivation practices. Explaining the cultivation process, Bhattacharya said it starts with well-composted and pasteurised paddy straw or similar substrate, which is layered with spawn in polythene bags Within 15-20 days, the mycelium completely colonises the substrate. After colonisation, a casing mixture of vermicompost, river sand, and slaked lime in the ratio of 3:1:0.5 is applied, sterilised by autoclaving for one hour at 121°C to maintain hygiene and prevent contamination, he said. Bhattacharya said the casing layer initiates fruiting, with pinheads emerging in 7-10 days, and mushrooms ready for harvest within 30-35 days of spawning. Each bag yields multiple flushes for up to 45-50 days, making it a sustainable enterprise, he said adding, milky mushroom offers farmers a profitable alternative to oyster mushrooms due to its high yield potential (800-1000g per kg of dry substrate), longer shelf life (4-5 days at room temperature, longer under refrigeration), and premium market value. He said farmers are taking keen interest in milky mushroom cultivation as they can earn Rs 250-300 per kg, making it a lucrative income source. Additionally, milky mushroom stands out for its nutritional richness-packed with protein (3-4%), dietary fiber, B-complex vitamins, vitamin C, and essential minerals such as calcium, iron, phosphorus, potassium, and zinc, Mishra said. It is low in fat and cholesterol-free and is considered a functional food ideal for health-conscious consumers. Its adaptability makes it especially suitable for the rainy season (April–Oct) when warm and humid conditions (25–35°C) naturally favour its growth. Mishra said the seasonal advantage ensures reliable production with minimal environmental control. With continuous guidance and training programmes, farmers are now expanding into year-round mushroom cultivation, diversifying into milky, button, and oyster mushrooms, thereby enhancing both livelihood opportunities and community nutrition security. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.

Glenmark, Alembic Pharma, Sun Pharma recall drugs in US, says USFDA
Glenmark, Alembic Pharma, Sun Pharma recall drugs in US, says USFDA

Business Standard

time6 hours ago

  • Business Standard

Glenmark, Alembic Pharma, Sun Pharma recall drugs in US, says USFDA

Drug makers Glenmark, Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due to manufacturing issues, according to the US health regulator. Mumbai-based Glenmark is recalling two products in the market, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. Glenmark Pharmaceuticals Inc, USA, a subsidiary of the company, is recalling Carvedilol tablets, used to treat heart failure, hypertension, and heart attack, in multiple strengths. The New Jersey-based firm is recalling 55,560 units of the affected lot due to "presence of a nitrosamine, N-Nitroso Carvedilol impurity above the current acceptable intake level," the USFDA stated. The company is also recalling 17,496 bottles of Carvedilol tablets as "results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm," it added. Glenmark initiated the Class II recall in August this year. USFDA said the company is also recalling 22,656 bottles of Theophylline extended-release tablets (400 mg) for failed dissolution specifications. Alembic Pharmaceuticals is recalling 9,492 bottles of Doxepin Hydrochloride capsules, used in the treatment of insomnia, the US health regulator stated. The Class II recall is due to the "Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit," it said. The company initiated the recall on July 25 this year. New Jersey-based Sun Pharmaceutical Industries Inc is recalling 11,328 bottles of Spironolactone Tablets, used to treat high blood pressure, due to "Presence of foreign substance: identified as aluminum," the regulator said. The company commenced the Class II recall on August 5. As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store